The Food and Drug Administration approved on Friday the first treatment for geographic atrophy, a progressive eye disease and a leading cause of blindness in older people.
The new drug, called Syfovre, is made by Apellis Pharmaceuticals.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
